143 related articles for article (PubMed ID: 26712520)
1. Estrogen receptor alpha (ESR1)-signaling regulates the expression of the taxane-response biomarker PRP4K.
Lahsaee S; Corkery DP; Anthes LE; Holly A; Dellaire G
Exp Cell Res; 2016 Jan; 340(1):125-31. PubMed ID: 26712520
[TBL] [Abstract][Full Text] [Related]
2. PRP4K is a HER2-regulated modifier of taxane sensitivity.
Corkery DP; Le Page C; Meunier L; Provencher D; Mes-Masson AM; Dellaire G
Cell Cycle; 2015; 14(7):1059-69. PubMed ID: 25602630
[TBL] [Abstract][Full Text] [Related]
3. Loss of PRP4K drives anoikis resistance in part by dysregulation of epidermal growth factor receptor endosomal trafficking.
Corkery DP; Clarke LE; Gebremeskel S; Salsman J; Pinder J; Le Page C; Meunier L; Xu Z; Mes-Masson AM; Berman JN; Johnston B; Dellaire G
Oncogene; 2018 Jan; 37(2):174-184. PubMed ID: 28892043
[TBL] [Abstract][Full Text] [Related]
4. Mammalian PRP4 kinase copurifies and interacts with components of both the U5 snRNP and the N-CoR deacetylase complexes.
Dellaire G; Makarov EM; Cowger JJ; Longman D; Sutherland HG; Lührmann R; Torchia J; Bickmore WA
Mol Cell Biol; 2002 Jul; 22(14):5141-56. PubMed ID: 12077342
[TBL] [Abstract][Full Text] [Related]
5. Haploinsufficient tumor suppressor PRP4K is negatively regulated during epithelial-to-mesenchymal transition.
Clarke LE; Cook A; Mathavarajah S; Bera A; Salsman J; Habib E; Van Iderstine C; Bydoun M; Lewis SM; Dellaire G
FASEB J; 2021 Nov; 35(11):e22001. PubMed ID: 34674320
[TBL] [Abstract][Full Text] [Related]
6. Curcumin induces radiosensitivity of in vitro and in vivo cancer models by modulating pre-mRNA processing factor 4 (Prp4).
Shehzad A; Park JW; Lee J; Lee YS
Chem Biol Interact; 2013 Nov; 206(2):394-402. PubMed ID: 24144778
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Yki/Yap subcellular localization and Hpo signaling by a nuclear kinase PRP4K.
Cho YS; Zhu J; Li S; Wang B; Han Y; Jiang J
Nat Commun; 2018 Apr; 9(1):1657. PubMed ID: 29695716
[TBL] [Abstract][Full Text] [Related]
8. Tinker, Tailor, Tumour Suppressor: The Many Functions of PRP4K.
Habib EB; Mathavarajah S; Dellaire G
Front Genet; 2022; 13():839963. PubMed ID: 35281802
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells.
Miah S; Bagu E; Goel R; Ogunbolude Y; Dai C; Ward A; Vizeacoumar FS; Davies G; Vizeacoumar FJ; Anderson D; Lukong KE
BMC Cancer; 2019 Jan; 19(1):78. PubMed ID: 30651078
[TBL] [Abstract][Full Text] [Related]
10. Multimodal Assessment of Estrogen Receptor mRNA Profiles to Quantify Estrogen Pathway Activity in Breast Tumors.
Muthukaruppan A; Lasham A; Woad KJ; Black MA; Blenkiron C; Miller LD; Harris G; McCarthy N; Findlay MP; Shelling AN; Print CG
Clin Breast Cancer; 2017 Apr; 17(2):139-153. PubMed ID: 27756582
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancer.
Kim C; Tang G; Pogue-Geile KL; Costantino JP; Baehner FL; Baker J; Cronin MT; Watson D; Shak S; Bohn OL; Fumagalli D; Taniyama Y; Lee A; Reilly ML; Vogel VG; McCaskill-Stevens W; Ford LG; Geyer CE; Wickerham DL; Wolmark N; Paik S
J Clin Oncol; 2011 Nov; 29(31):4160-7. PubMed ID: 21947828
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor alpha mediated induction of the transforming growth factor alpha gene by estradiol and 4-hydroxytamoxifen in MDA-MB-231 breast cancer cells.
MacGregor Schafer J; Liu H; Levenson AS; Horiguchi J; Chen Z; Jordan VC
J Steroid Biochem Mol Biol; 2001 Jul; 78(1):41-50. PubMed ID: 11530283
[TBL] [Abstract][Full Text] [Related]
13. Neo-tanshinlactone selectively inhibits the proliferation of estrogen receptor positive breast cancer cells through transcriptional down-regulation of estrogen receptor alpha.
Lin W; Huang J; Liao X; Yuan Z; Feng S; Xie Y; Ma W
Pharmacol Res; 2016 Sep; 111():849-858. PubMed ID: 27491559
[TBL] [Abstract][Full Text] [Related]
14. Sensitizing estrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor.
Weng SC; Kashida Y; Kulp SK; Wang D; Brueggemeier RW; Shapiro CL; Chen CS
Mol Cancer Ther; 2008 Apr; 7(4):800-8. PubMed ID: 18413793
[TBL] [Abstract][Full Text] [Related]
15. Comparison of tamoxifen and letrozole response in mammary preneoplasia of ER and aromatase overexpressing mice defines an immune-associated gene signature linked to tamoxifen resistance.
Dabydeen SA; Kang K; Díaz-Cruz ES; Alamri A; Axelrod ML; Bouker KB; Al-Kharboosh R; Clarke R; Hennighausen L; Furth PA
Carcinogenesis; 2015 Jan; 36(1):122-32. PubMed ID: 25421723
[TBL] [Abstract][Full Text] [Related]
16. Formulation of Anti-miR-21 and 4-Hydroxytamoxifen Co-loaded Biodegradable Polymer Nanoparticles and Their Antiproliferative Effect on Breast Cancer Cells.
Devulapally R; Sekar TV; Paulmurugan R
Mol Pharm; 2015 Jun; 12(6):2080-92. PubMed ID: 25880495
[TBL] [Abstract][Full Text] [Related]
17. Selenium disrupts estrogen receptor (alpha) signaling and potentiates tamoxifen antagonism in endometrial cancer cells and tamoxifen-resistant breast cancer cells.
Shah YM; Al-Dhaheri M; Dong Y; Ip C; Jones FE; Rowan BG
Mol Cancer Ther; 2005 Aug; 4(8):1239-49. PubMed ID: 16093440
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen resistance and metastasis of human breast cancer cells were mediated by the membrane-associated estrogen receptor ER-α36 signaling in vitro.
Gu W; Dong N; Wang P; Shi C; Yang J; Wang J
Cell Biol Toxicol; 2017 Apr; 33(2):183-195. PubMed ID: 27837347
[TBL] [Abstract][Full Text] [Related]
19. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
[TBL] [Abstract][Full Text] [Related]
20. Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells.
Yang Z; Barnes CJ; Kumar R
Clin Cancer Res; 2004 Jun; 10(11):3621-8. PubMed ID: 15173068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
